Literature DB >> 34480404

BMP2K phosphorylates AP-2 and regulates clathrin-mediated endocytosis.

Shikha T Ramesh1,2, Kolaparamba V Navyasree1,2, Sneha Sah1, Anjitha B Ashok1, Nishada Qathoon1, Suryasikha Mohanty3, Rajeeb K Swain3, Perunthottathu K Umasankar1.   

Abstract

Phosphorylation of the central adaptor protein complex, AP-2 is pivotal for clathrin-mediated endocytosis (CME). Here, we uncover the role of an uncharacterized kinase (BMP-2 inducible kinase-BMP2K) in AP-2 phosphorylation. We demonstrate that BMP2K can phosphorylate AP-2 in vitro and in vivo. Functional impairment of BMP2K impedes AP-2 phosphorylation leading to defects in clathrin-coated pit (CCP) morphology and cargo internalization. BMP2K engages AP-2 via its extended C-terminus and this interaction is important for its CCP localization and function. Notably, endogenous BMP2K levels decline upon functional impairment of AP-2 indicating AP-2 dependent BMP2K stabilization in cells. Further, functional inactivation of BMP2K in zebrafish embryos yields gastrulation phenotypes which mirror AP-2 loss-of-function suggesting physiological relevance of BMP2K in vertebrates. Together, our findings propose involvement of a novel kinase in AP-2 phosphorylation and in the operation of CME.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  BMP2K; adaptor protein complex AP-2; clathrin-mediated endocytosis; phosphorylation

Mesh:

Substances:

Year:  2021        PMID: 34480404     DOI: 10.1111/tra.12814

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  1 in total

1.  SSTP1, a Host Defense Peptide, Exploits the Immunomodulatory IL6 Pathway to Induce Apoptosis in Cancer Cells.

Authors:  Shyla Gopalakrishnan; Soumya Krishnan Uma; Gayathri Mohan; Amrutha Mohan; Geetha Shanmugam; Vineeth T V Kumar; Sreekumar J; Sivakumar K Chandrika; Dileep Vasudevan; Sai Ravi Chandra Nori; Shijulal Nelson Sathi; Sanil George; Tessy Thomas Maliekal
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.